Author

C. Shibao

h-index 39 View on Semantic Scholar

We have 2 of 222 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Nirmatrelvir-ritonavir targeting viral persistence in post-COVID-19 condition (long COVID) in the USA (RECOVER-VITAL): a randomised, double-blind, placebo-controlled, phase 2 trial.

BACKGROUND Post-acute sequelae of SARS-CoV-2 infection, more commonly known as long COVID, has emerged as a major health problem. The pathogenesis of long COVID is unknown, but among the leading hypotheses is viral persistence. We aimed to investigate whether the use of the SARS-CoV-2 antiviral nirmatrelvir-ritonavir i...

L. Baden, N. Shah, Sean T. H. Liu et al. · Lancet. Infectious Diseases... · 0 citations

Open access Jul 2026

Prospective Validation of the Movement Disorder Society Prodromal Multiple System Atrophy Criteria in Pure Autonomic Failure

The PP-MSA criteria demonstrate high sensitivity but limited specificity in patients with PAF and a stricter olfactory threshold improves diagnostic performance and may enhance cohort enrichment for clinical trials.

Patricio Millar Vernetti, J. Palma, I. Biaggioni et al. · Movement Disorders · 1 citation